BG
DOX icon

Bahl & Gaynor’s Amdocs DOX Stock Holding History

Bahl & Gaynor’s Portfolio DOX Stock Details DOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8M Sell
432,132
-49,349
-10% -$3.03M 0.1% 128
2026
Q1 		$31.4M Sell
481,481
-52,132
-10% -$3.81M 0.16% 114
2025
Q4 		$43M Sell
533,613
-18,121
-3% -$1.46M 0.22% 100
2025
Q3 		$45.3M Buy
551,734
+9,189
+2% +$797K 0.22% 99
2025
Q2 		$49.5M Sell
542,545
-49,552
-8% -$4.43M 0.25% 93
2025
Q1 		$54.2M Buy
592,097
+160,424
+37% +$14M 0.28% 81
2024
Q4 		$36.8M Sell
431,673
-15,108
-3% -$1.33M 0.19% 90
2024
Q3 		$39.1M Buy
446,781
+31,529
+8% +$2.65M 0.2% 86
2024
Q2 		$32.8M Buy
415,252
+9,765
+2% +$803K 0.18% 86
2024
Q1 		$36.6M Buy
405,487
+28,171
+7% +$2.57M 0.2% 78
2023
Q4 		$33.2M Buy
377,316
+9,436
+3% +$786K 0.2% 80
2023
Q3 		$31.1M Buy
367,880
+29,927
+9% +$2.7M 0.2% 77
2023
Q2 		$33.4M Buy
337,953
+45,076
+15% +$4.24M 0.2% 75
2023
Q1 		$28.1M Buy
292,877
+39,517
+16% +$3.66M 0.15% 79
2022
Q4 		$23M Buy
253,360
+33,341
+15% +$2.84M 0.14% 84
2022
Q3 		$17.5M Buy
220,019
+16,783
+8% +$1.42M 0.12% 87
2022
Q2 		$16.9M Buy
203,236
+68,385
+51% +$5.64M 0.11% 91
2022
Q1 		$11.1M Sell
134,851
-56,410
-29% -$4.42M 0.08% 103
2021
Q4 		$14.3M Buy
191,261
+35,876
+23% +$2.69M 0.08% 101
2021
Q3 		$11.8M Buy
155,385
+6,889
+5% +$533K 0.07% 104
2021
Q2 		$11.5M Sell
148,496
-3,279
-2% -$253K 0.07% 106
2021
Q1 		$10.6M Buy
151,775
+780
+0.5% +$58.9K 0.07% 109
2020
Q4 		$10.7M Buy
150,995
+15,266
+11% +$958K 0.07% 106
2020
Q3 		$7.79M Buy
135,729
+18,557
+16% +$1.11M 0.06% 113
2020
Q2 		$7.13M Buy
117,172
+8,163
+7% +$504K 0.05% 117
2020
Q1 		$5.99M Buy
109,009
+17,348
+19% +$1.16M 0.05% 119
2019
Q4 		$6.62M Buy
91,661
+3,630
+4% +$247K 0.05% 124
2019
Q3 		$5.82M Buy
88,031
+5,487
+7% +$353K 0.04% 129
2019
Q2 		$5.13M Buy
82,544
+6,061
+8% +$350K 0.04% 137
2019
Q1 		$4.14M Buy
76,483
+56,179
+277% +$3.16M 0.04% 145
2018
Q4 		$1.19M Sell
20,304
-865
-4% -$54.2K 0.01% 240
2018
Q3 		$1.4M Buy
21,169
+155
+0.7% +$10.3K 0.02% 245
2018
Q2 		$1.39M Buy
21,014
+394
+2% +$26.5K 0.01% 247
2018
Q1 		$1.38M Sell
20,620
-425
-2% -$28.6K 0.02% 246
2017
Q4 		$1.38M Hold
21,045
– – 0.01% 252
2017
Q3 		$1.35M Buy
21,045
+1,700
+9% +$110K 0.01% 236
2017
Q2 		$1.25M Buy
19,345
+893
+5% +$56.4K 0.01% 241
2017
Q1 		$1.13M Buy
18,452
+4,094
+29% +$246K 0.01% 242
2016
Q4 		$836K Buy
14,358
+150
+1% +$8.85K 0.01% 261
2016
Q3 		$822K Buy
14,208
+325
+2% +$19.1K 0.01% 262
2016
Q2 		$801K Buy
13,883
+690
+5% +$39.6K 0.01% 253
2016
Q1 		$797K Buy
13,193
+6,842
+108% +$383K 0.01% 254
2015
Q4 		$347K Buy
+6,351
New +$364K ﹤0.01% 353

Other funds holding DOX

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bahl & Gaynor's DOX Position: Q2 2026 in Review

Bahl & Gaynor reduced its Amdocs (DOX) stake by 10% in Q2 2026, selling an estimated $3.03M and leaving 432,132 shares worth $21.8M. The position accounts for 0.1% of the portfolio, ranked #128.

Bahl & Gaynor first reported a position in DOX in Q4 2015 and has held it in 43 quarters since. The position peaked at $54.2M in Q1 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Bahl & Gaynor held 432,132 shares of Amdocs worth $21.8M as of Q2 2026.
  • Bahl & Gaynor sold 49,349 Amdocs shares in Q2 2026, an estimated $3.03M.
  • Amdocs made up 0.1% of Bahl & Gaynor's portfolio in Q2 2026, its #128 holding.
  • Bahl & Gaynor first reported a position in Amdocs in Q4 2015 and has held it in 43 quarters since.
  • Bahl & Gaynor's Amdocs position peaked at $54.2M in Q1 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.